13F-HR filed by SAMSARA BIOCAPITAL, LLC
SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-17, with 43 holding rows worth $994,430,000 by the sum of the rows.
- Accession
- 0001104659-21-024479
- Filer
- CIK 1744967
- Filed
- 2021-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 44 entries on the cover page, a total value of $492,611,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $994,430,000 with VALUE read as thousands by filing date, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.
The cover page states a total of $492,611,000, 50% less than the sum of the rows, $994,430,000. This page uses the sum of the rows.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JIYA ACQUISITION CORP | 47760M102 | CMN | 5,223 | $507,041,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,034,703 | $125,073,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 3,168,388 | $50,251,000 | thousands by filing date | |
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,418,529 | $49,507,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 1,675,579 | $36,377,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 2,189,199 | $21,837,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 146,259 | $20,476,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 262,572 | $19,042,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,372,476 | $16,396,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 815,421 | $15,656,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 403,688 | $9,971,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,362,612 | $8,816,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,111,112 | $7,778,000 | thousands by filing date | |
| CUREVAC N V | N2451R105 | COM | 95,318 | $7,727,000 | thousands by filing date | |
| ATRECA INC | 04965G109 | COM | 474,943 | $7,670,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 883,720 | $6,955,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 588,961 | $6,614,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 201,046 | $5,977,000 | thousands by filing date | |
| EQUILLIUM INC | 29446K106 | COM | 1,074,285 | $5,747,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 500,000 | $5,720,000 | thousands by filing date | |
| PANACEA ACQUISITION CORP | 698102209 | UNIT 99/99/9999 | 400,000 | $5,104,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 399,190 | $5,030,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 166,250 | $4,966,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 601,162 | $4,076,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 100,000 | $3,751,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 63,770 | $3,497,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 294,118 | $3,444,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 30,160 | $3,363,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 300,000 | $3,342,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 1,640,368 | $3,182,000 | thousands by filing date | |
| ALLOVIR INC | 019818103 | COM | 82,336 | $3,165,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 300,000 | $3,141,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 434,250 | $2,901,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 200,000 | $2,134,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,224,870 | $1,948,000 | thousands by filing date | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 129,660 | $1,438,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 67,270 | $1,277,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 25,000 | $1,159,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 10,795 | $880,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 165,000 | $685,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 300,000 | $642,000 | thousands by filing date | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 18,225 | $552,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 25,000 | $122,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-024479 | this filing | 2021-02-17 | acceptance time not in the bulk data set |